Interest in Marijuana, Cannabinoids for Pain Rising Rapidly
FRIDAY, Aug. 30, 2019 -- There is rapidly growing interest in the use of marijuana and cannabinoids for pain, according to a survey commissioned by the American Society of Anesthesiologists (ASA).
The five-question CARAVAN Survey was conducted online by Engine during Aug. 5 to 7, 2019; 1,005 U.S. adults (503 men and 502 women) were surveyed. The survey was released in time for September's Pain Awareness Month.
The results of the survey indicate that overall, more than two-thirds of respondents have used or would consider using marijuana or cannabinoid compounds, including cannabidiol (CBD) and tetrahydrocannabinol, to manage pain. Among millennials, nearly three-quarters would consider using marijuana or cannabinoid compounds for pain compared with two-thirds of Gen Xers and baby boomers. However, some of the results demonstrate significant misunderstanding among those surveyed. For instance, 62 percent believe marijuana or cannabinoid compounds are safer than opioids and 57 percent believe they have fewer side effects than other medications. More than one-third of respondents do not think they need to discuss use of these products with their doctor. Nearly half of respondents think they know what they are getting with marijuana or cannabinoids, while 40 percent believe cannabidiol sold at grocery stores, truck stops, health food stores, or medical marijuana dispensaries is approved by the U.S. Food and Drug Administration.
"As experts in managing pain, physician anesthesiologists are concerned about the lack of research regarding the safety and effectiveness of marijuana and cannabinoids," Linda J. Mason, M.D., president of the ASA, said in a statement.
© 2020 HealthDay. All rights reserved.
Posted: August 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.